https://www.selleckchem.com/pr....oducts/cdk2-inhibito
78, p = 0.046) and change in surgical strategy (OR = 5.30, p = 0.023). Functional class III-IV (OR = 6.98, p 0.001), renal failure (OR = 5.75, p = 0.001), CIED infection (OR = 13.30, p 0.001), number of procedures performed (OR = 77.32, p 0.001) and major intraoperative complications (OR = 38.84, p 0.001) were predictors of 30-day mortality. The results of this study, which is the largest prospective registry of consecutive TLE procedures in Latin America, confirm the safety and effectiveness of this procedure
Like
Comment
Share
